TORRENT PHARMACEUTICALS
Back to Income Statement
|
TORRENT PHARMACEUTICALS Last 5 Year Total Expenditure History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Expenditure | ₹6,796 Cr | ₹6,077 Cr | ₹5,524 Cr | ₹5,769 Cr | ₹5,696 Cr |
What is the latest Total Expenditure of TORRENT PHARMACEUTICALS ?
Year | Total Expenditure |
---|---|
Mar2024 | ₹6,796 Cr |
Mar2023 | ₹6,077 Cr |
Mar2022 | ₹5,524 Cr |
Mar2021 | ₹5,769 Cr |
Mar2020 | ₹5,696 Cr |
How is Total Expenditure of TORRENT PHARMACEUTICALS Trending?
Years | Total Expenditure | % Change | |
---|---|---|---|
Mar2024 | ₹6,796 Cr | 11.84 | |
Mar2023 | ₹6,077 Cr | 10.00 | |
Mar2022 | ₹5,524 Cr | -4.24 | |
Mar2021 | ₹5,769 Cr | 1.28 | |
Mar2020 | ₹5,696 Cr | - |
Compare Total Expenditure of peers of TORRENT PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
TORRENT PHARMACEUTICALS | ₹108,927.6 Cr | 1.4% | 1.3% | 17% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹405,068.0 Cr | 1.6% | -2.9% | 17.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹177,105.0 Cr | 1.5% | 10.4% | 51.9% | Stock Analytics | |
CIPLA | ₹122,016.0 Cr | 2.3% | 1.9% | 2.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹112,651.0 Cr | 5.7% | 14.1% | 15.2% | Stock Analytics | |
MANKIND PHARMA | ₹98,130.4 Cr | 0.2% | -2.4% | 12.5% | Stock Analytics |
TORRENT PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
TORRENT PHARMACEUTICALS | 1.4% |
1.3% |
17% |
SENSEX | 2.1% |
3.7% |
14.3% |
You may also like the below Video Courses